Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL
Saved in:
| Main Authors: | Adam S. Kittai, Ying Huang, Sarah Miller, John N. Allan, Seema A. Bhat, David A. Bond, Danielle M. Brander, John C. Byrd, Julio C. Chavez, Elise Chong, Matthew S. Davids, Alexey V. Danilov, Wei Ding, Mark R. Dowling, Kaitlyn Dvorak-Kornaus, Hannah Freedman, Paul J. Hampel, Carrie Ho, Steven R. Hwang, Prioty Islam, Nikita Malakhov, Matthew Matasar, Cecelia Miller, Zulfa Omer, Sameer A. Parikh, Erin Parry, Kari G. Rabe, Philipp W. Raess, Manoj Rai, Lindsey Roeker, Joanna Rhodes, Kerry A. Rogers, Aditi Saha, Jake Schade, Hamish W. Scott, Mazyar Shadman, Geoffrey Shouse, Alan Skarbnik, Stephen Spurgeon, Deborah M. Stephens, Meghan C. Thompson, Philip A. Thompson, Yucai Wang, Max Yano, Jennifer A. Woyach |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-02-01
|
| Series: | Blood Cancer Journal |
| Online Access: | https://doi.org/10.1038/s41408-025-01236-6 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Safety and efficacyof the combination of copanlisib and nivolumab in patients with Richter’s transformation or transformed non-Hodgkin lymphoma: results from a phase I trial
by: Geoffrey Shouse, et al.
Published: (2025-07-01) -
3: Comparing and contrasting karyotype scoring guidelines for evaluating complex karyotype in chronic lymphocytic leukemia
by: Cecelia R. Miller, et al.
Published: (2025-01-01) -
Lisocabtagene Maraleucel for Richter's Transformation—A Case Series
by: Courtney J. Smith, et al.
Published: (2025-04-01) -
A question of TiME: how microenvironmental interactions shape response to immunotherapy in CLL and Richter Transformation
by: Alexander F. vom Stein, et al.
Published: (2025-05-01) -
Peyton E. Richter (ed.), Utopia/Dystopia
by: Ute Schmidt Osmanczik
Published: (2018-11-01)